February 3, 2020

Clinical Trial

Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in Exudative Age-Related Macular Degeneration: 52- and 96-Week Findings from ALTAIR : A Randomized Controlled Trial.

Ohji M, Takahashi K, Okada AA, Kobayashi M, Matsuda Y, Terano Y.

Adv Ther. 2020 Mar;37(3):1173-1187.
Full text | Metrics.

Share This Article :

Updated on January 24th, 2022

Source Archive